OnKure Therapeutics annual return on equity
2021
2022
2024
2025
OnKure Therapeutics Return on Equity (ROE) Growth & History (OKUR)
OnKure Therapeutics's return on equity was −74.39% for fiscal 2025.
View full OnKure Therapeutics company overviewOnKure Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −74.39% | +5230.04 pp |
| 2024 | 2024-12-31 | −5,304.43% | — |
| 2022 | 2022-12-31 | −111.98% | −36.30 pp |
| 2021 | 2021-12-31 | −75.68% | — |
OnKure Therapeutics quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −8.61% | +9.62 pp |
| Q1 2026 | 2026-03-31 | −12.60% | +3.77 pp |
| Q4 2025 | 2025-12-31 | −22.03% | — |
| Q3 2025 | 2025-09-30 | −20.33% | — |
| Q2 2025 | 2025-06-30 | −18.23% | — |
| Q1 2025 | 2025-03-31 | −16.38% | — |
| Q4 2023 | 2023-12-31 | 282.75% | +329.95 pp |
| Q3 2023 | 2023-09-30 | −15.51% | −4.50 pp |
| Q2 2023 | 2023-06-30 | −17.79% | −8.30 pp |
| Q1 2023 | 2023-03-31 | −92.49% | −83.27 pp |
| Q4 2022 | 2022-12-31 | −47.20% | −40.21 pp |
| Q3 2022 | 2022-09-30 | −11.01% | −3.15 pp |
| Q2 2022 | 2022-06-30 | −9.49% | +6.02 pp |
| Q1 2022 | 2022-03-31 | −9.23% | — |
| Q4 2021 | 2021-12-31 | −6.99% | — |
| Q3 2021 | 2021-09-30 | −7.87% | — |
| Q2 2021 | 2021-06-30 | −15.51% | — |
OnKure Therapeutics return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, OnKure Therapeutics's return on equity increased from −75.68% to −74.39%, a change of +1.29 percentage points. The latest reported quarter, Q2 2026, shows −8.61%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OnKure Therapeutics source filings ↗